Quest Diagnostics Inc vs Petróleo Brasileiro SA — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Petróleo Brasileiro SA trades at $17.77 (market cap $112.19B). The key difference: Petróleo Brasileiro SA is far larger — about 4.3× Quest Diagnostics Inc's market cap, and Petróleo Brasileiro SA pays the higher dividend (9.42%). Which is the better fit depends on your goals.
| DGX | PBR | |
|---|---|---|
Market Cap | $26.21B | $112.19B |
Sector | Health | Technology |
52-Week High | $238.50 | $22.03 |
52-Week Low | $173.49 | $11.54 |
Enterprise Value | $31.97B | $172.61B |
Dividend Yield | 1.45% | 9.42% |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →